(Q41713825)

7 October 2017

Complement alternative pathway activation and control on membranes of human lymphoid B cell lines (English)

1 reference

https://api.crossref.org/works/10.1002/EJI.1830201218

3 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702720

complement activation, alternative pathway

3 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702720

3 November 2022

1 reference

https://api.crossref.org/works/10.1002/EJI.1830201218

3 November 2022

2

F. Porteu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702720

3 November 2022

author name string

Halbwachs-Mecarelli L

5

1 reference

7 October 2017

V. Caudwell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702720

3 November 2022

A. Calender

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702720

3 November 2022

M. K. Pangburn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702720

3 November 2022

L. Halbwachs-Mecarelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702720

3 November 2022

language of work or name

English

0 references

publication date

1 December 1990

1 reference

full work available at URL

7 October 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Feji.1830201218

1 reference

https://api.crossref.org/works/10.1002/EJI.1830201218

https://onlinelibrary.wiley.com/doi/full/10.1002/eji.1830201218

3 November 2022

1 reference

https://api.crossref.org/works/10.1002/EJI.1830201218

European Journal of Immunology

3 November 2022

published in

1 reference

7 October 2017

20

1 reference

7 October 2017

12

1 reference

7 October 2017

2643-2650

1 reference

Purification of human C3b inactivator by monoclonal-antibody affinity chromatography

7 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

Activation of the alternative complement pathway by normal and transformed cells in homologous and heterologous sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Prevention of complement activation on the homologous cell membrane of nucleated cells as well as erythrocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Separation of self from non-self in the complement system.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Structural gene for human membrane cofactor protein (MCP) of complement maps to within 100 kb of the 3' end of the C3b/C4b receptor gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Decay-accelerating factor: biochemistry, molecular biology, and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Complement receptor is an inhibitor of the complement cascade

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Functional and antigenic properties of complement receptor type 2, CR2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Virus-infected cells, IgG, and the alternative complement pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Relationships between complement activation, complement binding, and EBV absorption by human hematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Third component of human complement: purification from plasma and physicochemical characterization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Modulation of the alternative complement pathways by beta 1 H globulin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Monoclonal antibody GB24 recognizes a trophoblast-lymphocyte cross-reactive antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Cross-reactivity of a normal human cell surface antigen with primate retrovirus glycoproteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Interferon amplifies complement activation by Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

An intricate route to immortality

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

fgr proto-oncogene mRNA induced in B lymphocytes by Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830201218

7 January 2021

Identifiers

1 reference

7 October 2017

1 reference